Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy
- Squifflet, P.
- Saad, E.D.
- Loibl, S.
- van Mackelenbergh, M.T.
- Untch, M.
- Rastogi, P.
- Gianni, L.
- Schneeweiss, A.
- Conte, P.
- Piccart, M.
- Bonnefoi, H.
- Jackisch, C.
- Nekljudova, V.
- Tang, G.
- Valagussa, P.
- Neate, C.
- Gelber, R.
- Poncet, C.
- Heinzmann, D.
- Denkert, C.
- Geyer, C.E.
- Cortes, J.
- Guarneri, V.
- de Azambuja, E.
- Cameron, D.
- Ismael, G.
- Wolmark, N.
- Cortazar, P.
- Buyse, M.
- Mostrar todos los/as autores/as +
ISSN: 1527-7755
Año de publicación: 2023
Volumen: 41
Número: 16
Páginas: 2988-2997
Tipo: Artículo